Baja el precio de las drogas para adelgazar que matan el apetito y ahora dos países detectan un raro fenómeno

AI justification

Systemic risks to public health and nutrition outweigh potential benefits of weight-loss drugs. | The increased access to weight-loss drugs presents a dual ethical challenge. While it may improve individual health outcomes (SDG 3), it risks distorting food industry practices and exacerbating health disparities, particularly for vulnerable populations. The net ethical position is mixed, with significant concerns about systemic impacts on nutrition and equity.